Press

ProNAi Reports Significant Activity and Ongoing Durable Responses in Relapsed or Refractory Non-Hodgkin's Lymphoma with PNT2258

December 5, 2014

Rugged Computer Keeps Running After It’s Dropped in an Aquarium [LiquidCool Solutions]

November 4, 2014

ProNAi Therapeutics Strengthens Senior Management Team to Advance DNAi®-based Oncology Therapeutics

October 22, 2014

OnKol Wants to Help Grandma Join the Internet of Things Movement

September 10, 2014

ProNAi Therapeutics, Inc. Names New President and Chief Executive Officer

September 3, 2014

ProNAi Therapeutics Raises $59.5 Million Series D Financing

April 21, 2014

ProNAi Therapeutics Secures $12 Million Series C Financing to Expand Phase II Cancer Studies for PNT2258, a Novel BCL2 Inhibitor, in Defined Lymphoma Patients

January 13, 2014

LiquidCool Solutions Receives the 2013 North American Frost & Sullivan Customer Value Enhancement Award in Data Center Cooling

December 17, 2013

LiquidCool Solutions and Dedicated Computing Form Strategic Alliance to Develop Liquid Cooled Technical Computing Solutions

September 5, 2013

Great Lakes Pharmaceuticals, Inc. Announces Initiation of Clinical Trial of the Catheter Lock Solution, B-Lock™

July 26, 2012

CytoPherx Raises $34 Million to Move Into U.S. Clinical Trials

January 4, 2012

Sun Cofounder Evangelizes Liquid Blade Server [LiquidCool Solutions]

May 4, 2011

Therapeutic Proteins Inc. Completes First Independent, Dedicated Biosimilars Manufacturing Facility in U.S.

April 23, 2010

Contact

10556 N Port Washington Rd
Ste 201
Mequon, WI 53092

(414) 453-4488